Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve who wrote (238)	8/4/1998 8:10:00 AM
From: Dr. Bob	of 496

Small caps and biotechs are doing poorly all over. GLFD's decline is similar to that of most of the other small caps I hold - nothing remarkable there. Most biotechs (ENMD is a notable exception) do not soar until they have a drug nearing the end of phase III trials. In the meantime, the only way to value a biotech is the 8x R&D example that Michael Murphy uses, which is about where GLFD is. There have been many opportunities to buy this in the 16 - 20 range over the past year, so anyone whose basis is more than that is just unlucky, but hard to claim this stock hasn't held its value as well as its peers. Definitely have to buy this with a long term perspective, but with the idea that it could pop at any time, when/if a breakthrough is announced with one of the several areas they are working on. Is it going down further in the meantime? It could, but that's true of all of the other stocks I own, and the downside here is a lot less than some of the ones I have, IMO. Bottom line? I'd rather read the scientific reports than the analyst reports - they still tell me this company has tremendous upside, too, and I don't have to worry about how they came to that conclusion! Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next